NCT07313423

Brief Summary

  • A total of 60 overweight women (BMI 25-29.9 kg/m²), aged 18-50years, will be enrolled and randomized equally into intervention and control groups. The intervention group will consume a 5 g freshly prepared seabuckthorn aqueous infusion daily for 12 weeks, while controls maintain usual habits without supplementation.
  • The seabuckthorn aqueous infusion will be prepared by using 250mL of potable boiled water and then cooled to a lukewarm temperature (around 40-45°C). At this point, 5 g of seabuckthorn powder will be added, stirred thoroughly until fully dispersed, and consumed immediately. The infusion will be freshly prepared once daily and administered in the morning after breakfast. Measurements will be conducted using the InBody 270, a validated bioelectrical impedance analyzer employed in this study to obtain accurate assessments of body weight, body mass index (BMI), waist-hip ratio, and visceral fat levels. The device offers segmental analysis and visceral fat estimation through non-invasive, standardized procedures, ensuring consistency and reliability in longitudinal tracking.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 17, 2025

Completed
15 days until next milestone

Study Start

First participant enrolled

January 1, 2026

Completed
1 day until next milestone

First Posted

Study publicly available on registry

January 2, 2026

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 30, 2026

Completed
16 days until next milestone

Study Completion

Last participant's last visit for all outcomes

April 15, 2026

Completed
Last Updated

January 2, 2026

Status Verified

December 1, 2025

Enrollment Period

3 months

First QC Date

December 17, 2025

Last Update Submit

December 17, 2025

Conditions

Keywords

sea buckthornaqueous infusionbody composition

Outcome Measures

Primary Outcomes (2)

  • Body weight

    unit of measurement in kilograms will be measured by weight machine

    12 weeks

  • Body mass index

    body mass index will be measured using body mass index calculator

    at the end of intervention (12 week)

Secondary Outcomes (2)

  • visceral fat

    at the end of intervention period (12 week)

  • waist-hip ratio

    at the end of intervention period ( 12 week)

Study Arms (2)

1

PLACEBO COMPARATOR

The participants in the control group will consume placebo that will match in appearance to the supplement and is used to maintain blinding. Participants will consume freshly prepared sea buckthorn aqueous infusion daily for 12 weeks.

Dietary Supplement: Sea buckthorn aqueous infusion

2

EXPERIMENTAL

Drug (Sea buckthorn aqueous infusion) The participants will consume Sea buckthorn aqueous infusion supplementation daily for 12 weeks. it will be prepared by using 5g sb powder in 250 ml of water.

Dietary Supplement: Sea buckthorn aqueous infusion

Interventions

Sea buckthorn aqueous infusion prepared by using 5g powder in 250 ml water.

12

Eligibility Criteria

Age18 Years - 50 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of veterinary and animal sciences, Lahore

Lahore, Punjab Province, 5400, Pakistan

RECRUITING

Central Study Contacts

Eesha Naeem, Post graduate

CONTACT

Dr. Qaisar Raza, Phd

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants will be randomly assigned into two groups in a 1: 1 ratio to either the treatment group (sea buckthorn aqueous infusion) or control group (placebo), both groups will be followed concurrently for 12 weeks to assess changes in bmi, body weight, visceral fat and waist-hip ratio.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant professor

Study Record Dates

First Submitted

December 17, 2025

First Posted

January 2, 2026

Study Start

January 1, 2026

Primary Completion

March 30, 2026

Study Completion

April 15, 2026

Last Updated

January 2, 2026

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Locations